PMID- 36186796
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221004
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Case report: Total percutaneous post-closure of femoral arterial access sites 
      after veno-arterial extracorporeal membrane oxygenation.
PG  - 980122
LID - 10.3389/fmed.2022.980122 [doi]
LID - 980122
AB  - Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) which is a form of 
      circulatory and gas exchange support. Following VA-ECMO, total percutaneous 
      closure of the site of femoral arterial puncture with perclose Proglide (PP) has 
      become widespread, enhancing patient comfort and lessening the incidence of wound 
      infections and lymphatic fistulas in a short closure time. The preclose technique 
      with perclose Proglide provides numerous benefits, however, it prolongs extra 
      time during the VA-ECMO procedure, adds additional post-operative care to 
      workloads, and increases the potential for Proglide stitch infection. The 
      modified technique-percutaneous post-closure, described here by a case of a 
      65-year-old man with heart attack who underwent VA-ECMO, is a simple, rapidly 
      applied technique to wean VA-ECMO also suitable for emergency cannulation. The 
      patient was administered mechanically ventilated and sedated and the femoral 
      artery access site and evaluated by ultrasound for precise positioning, then the 
      VA-ECMO arterial cannula was withdrawn, and a 0.035-in guidewire was left in the 
      artery. The first set of sutures was deployed after the Proglide device was 
      inserted over the guidewire. The second sutures were then replaced in the same 
      way but at a different angle. After hemostasis was achieved, the guidewire was 
      removed, and additional manual compression was used to control any residual blood 
      seeping. No hematoma, pseudoaneurysm, major bleeding, minor bleeding, acute 
      arterial thrombosis, arteriovenous fistula, groin infection, lymphocele, or 
      arterial dissection and stenosis occurred during the periprocedural period or 
      during the 30-day post-procedural follow-up. In conclusion, the standardized 
      algorithm we established, total percutaneous post-closure of femoral 
      arteriotomies utilizing Perclose ProGlide device is feasible and safe with a low 
      incidence of access site complications.
CI  - Copyright (c) 2022 Tian, Zhang, Zhang, Xu, Xu, Liu and Huang.
FAU - Tian, Lun
AU  - Tian L
AD  - Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
FAU - Zhang, Libin
AU  - Zhang L
AD  - Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
FAU - Zhang, Naiding
AU  - Zhang N
AD  - Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
FAU - Xu, Xin
AU  - Xu X
AD  - Department of Intensive Care Unit, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
FAU - Xu, Yongshan
AU  - Xu Y
AD  - Department of Intensive Care Unit, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
FAU - Liu, Zhenjie
AU  - Liu Z
AD  - Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
FAU - Huang, Man
AU  - Huang M
AD  - Department of Intensive Care Unit, The Second Affiliated Hospital of Zhejiang 
      University School of Medicine, Hangzhou, China.
LA  - eng
PT  - Case Reports
DEP - 20220915
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9520057
OTO - NOTNLM
OT  - Perclose Proglide
OT  - VA-ECMO
OT  - arteriotomies
OT  - integrated algorithm
OT  - suture-mediated closure device
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/10/04 06:00
MHDA- 2022/10/04 06:01
PMCR- 2022/09/15
CRDT- 2022/10/03 04:40
PHST- 2022/06/28 00:00 [received]
PHST- 2022/08/15 00:00 [accepted]
PHST- 2022/10/03 04:40 [entrez]
PHST- 2022/10/04 06:00 [pubmed]
PHST- 2022/10/04 06:01 [medline]
PHST- 2022/09/15 00:00 [pmc-release]
AID - 10.3389/fmed.2022.980122 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Sep 15;9:980122. doi: 10.3389/fmed.2022.980122. 
      eCollection 2022.